Search
Sharan Murugan
Dec 5, 20212 min read
Guidance on QPPV including Pharmacovigilance System Master Files– MHRA
UK Medicines and Healthcare products Regulatory Agency (MHRA) updated its guidance on requesting a pharmacovigilance system master file...
31 views0 comments
Sharan Murugan
Nov 30, 20211 min read
Draft Guidance on Assessing Registries to Support Regulatory Decision -USFDAYesterday, the USFDA
Yesterday, the USFDA issued draft guidance for the industry titled Real-World Data: Assessing Registries to Support Regulatory...
18 views0 comments
Sharan Murugan
Nov 28, 20212 min read
Guidance for Declaration of Conformity - TGA
When applying for inclusion in the Australian Register of Therapeutic Goods (ARTG), different classes of medical device require different...
124 views0 comments
Sharan Murugan
Nov 20, 20211 min read
MHRA’s updated Guidance on URGENT SAFETY MEASURE – UK
This guidance has been developed to assist those involved in clinical trials disrupted as a result of COVID-19. It is relevant to those...
312 views0 comments
Sharan Murugan
Nov 14, 20211 min read
Pharmaceutical Reference Standard – Guidance Update - SFDA
Standards and reference substances play a vital role in evaluating the quality of active pharmaceutical ingredients and finished...
56 views0 comments
Sharan Murugan
Nov 14, 20211 min read
Post-Authorisation Procedural Advice for Users of the Centralised Procedure – Updated guideline EMA
This guidance document addresses a number of questions that marketing authorisation holders (MAHs) may have on post-authorisation...
39 views0 comments
Sharan Murugan
Nov 7, 20211 min read
Knowledge aided Assessment and Structured Application (KASA) Initiative
The current challenges with the eCTD system that the agency currently uses, explaining how it does “not follow the development flow of...
129 views0 comments
Sharan Murugan
Nov 7, 20211 min read
Draft Guidance for Device Software in Premarket Submissions - USFDA
This guidance document is intended to provide information regarding the recommended documentation sponsors should include in premarket...
11 views0 comments